MEROPENEM Side Effects

7020062-5 | Blood Creatine Phosphokinase Increased, Hypertriglyceridaemia, Renal Failure, Rhabdomyolysis, Sepsis
on Sep 20, 2010 Male patient from AUSTRALIA , 48 years of age, weighting 209.4 lb, was diagnosed with xanthomatosis and was treated with Meropenem (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatine phosphokinase increased, hypertriglyceridaemia, renal failure, rhabdomyolysis, sepsis (What is sepsis?). Meropenem dosage: . During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), CRESTOR (View Crestor Review and Crestor Label ), ERYTHROMYCIN (View Erythromycin Review and Erythromycin Label ), FENOFIBRATE (View Fenofibrate Review and Fenofibrate Label ), NILSTAT (View Nilstat Review and Nilstat Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ). Patient was hospitalized.

6984742-X | Pancytopenia
Patient was taking Meropenem (View Usage). Patient had the following side effects: pancytopenia on Sep 06, 2010 from SPAIN Additional patient health information: Male patient , 82 years of age, was diagnosed with respiratory tract infection, bone marrow transplant (What is bone marrow transplant?), neutropenia, prophylaxis, diabetes mellitus and. Meropenem dosage: 1000 Mg, Vial 30 Ml, 3g/day. During the same period patient was treated with ACYCLOVIR SODIUM (View Acyclovir Sodium Review and Acyclovir Sodium Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), AMIKACIN (View Amikacin Review and Amikacin Label ), CANCIDAS (50 Mg, Vial 10 Ml Sol. Perf.) (View Cancidas Review and Cancidas Label ), ZYVOX (2 Mg/ml Sol. Perf, 10 Bags Of 300 Ml, 0.6g/two Times A Day) (View Zyvox Review and Zyvox Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ), LANTUS (1000 Iu/l, Optiset 10 Precharged Pens) (View Lantus Review and Lantus Label ).

6984740-6 | Hepatitis, Hyperbilirubinaemia
Adverse event was reported on Sep 06, 2010 by a Female patient taking Meropenem (View Usage) (Dosage: ) was diagnosed with cholecystitis acute, abdominal pain (What is abdominal pain?), cardiac failure, chronic obstructive pulmonary disease and. Location: SPAIN , 34 years of age, After Meropenem was administered, patient had the following side effects: hepatitis (What is hepatitis?), hyperbilirubinaemia. During the same period patient was treated with PERFALGAN (10 Mg/ml Solution For Perfusion) (View Perfalgan Review and Perfalgan Label ), SEGURIL (20 Mg Injection Solution In Ampoules, 5 Ampoules Of 2 Ml) (View Seguril Review and Seguril Label ), URBASON (20 Mg Powder And Solvent For Injection Solution, 3 Lyophilized Ampoules+3 Solvent Ampoules) (View Urbason Review and Urbason Label ).

6976293-3 | Cholestasis
on Aug 20, 2010 Male patient from POLAND , weighting 7.72 lb, was diagnosed with pneumonia (What is pneumonia?), sepsis (What is sepsis?) and was treated with Meropenem (View Usage). Patient experienced the following unwanted or unexpected effects: cholestasis. Meropenem dosage: . During the same period patient was treated with TARGOCID (View Targocid Review and Targocid Label ), PERFALGAN (View Perfalgan Review and Perfalgan Label ), DIFLUCAN (View Diflucan Review and Diflucan Label ), DORMICUM (0.1 Mg/kg/h Daily) (View Dormicum Review and Dormicum Label ). Patient was hospitalized.


6976283-0 | Cerebrovascular Accident, Cholestasis, Haemorrhagic Diathesis, Thrombocytopenia
on Aug 20, 2010 Female patient from POLAND , weighting 3.31 lb, was diagnosed with sepsis (What is sepsis?), pneumonia (What is pneumonia?), systemic mycosis and was treated with Meropenem (View Usage). Patient had the following side effects: cerebrovascular accident, cholestasis, haemorrhagic diathesis, thrombocytopenia. Meropenem dosage: 3 X 30 Mg/24 H. During the same period patient was treated with ABELCET (5 Mg/kg/24 H) (View Abelcet Review and Abelcet Label ), TARGOCID (8 Mg/24 H) (View Targocid Review and Targocid Label ), PERFALGAN (3 X 7.5 Mg/kg) (View Perfalgan Review and Perfalgan Label ). Patient was hospitalized.

6976166-6 | Liver Injury, Sepsis
Patient was taking Meropenem (View Usage). After Meropenem was administered, patient had the following side effects: liver injury, sepsis (What is sepsis?) on Aug 20, 2010 from POLAND Additional patient health information: Male patient , weighting 5.29 lb, was diagnosed with infection (What is infection?), pneumonia (What is pneumonia?) and. Meropenem dosage: 3x30 Mg/kg/24 H. During the same period patient was treated with TARGOCID (8mg/kg/24 H) (View Targocid Review and Targocid Label ), AMPICYLINA (50 Mg/kg) (View Ampicylina Review and Ampicylina Label ), METRONIDAZOLE (15 Mg/kg) (View Metronidazole Review and Metronidazole Label ), CIPROFLOKSACYNA (5x5mg/kg/24h) (View Ciprofloksacyna Review and Ciprofloksacyna Label ). Patient was hospitalized.

6968978-X | Pancreas Infection, Pancreatic Cyst, Pruritus, Rash Erythematous, Rash Pruritic, Skin Plaque
Adverse event was reported on Sep 03, 2010 by a Male patient taking Meropenem (View Usage) (Dosage: ) was diagnosed with pain (What is pain?) and. Location: UNITED STATES , 41 years of age, weighting 165.3 lb, Patient experienced the following unwanted or unexpected effects: pancreas infection, pancreatic cyst, pruritus, rash erythematous, rash pruritic, skin plaque. Patient was hospitalized.

6960211-8 | Corynebacterium Infection
on Aug 23, 2010 Female patient from TURKEY , child 6 years of age, was diagnosed with pyrexia, leukaemia recurrent and was treated with Meropenem (View Usage). Patient had the following side effects: corynebacterium infection. Meropenem dosage: . During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), AMIKACIN (View Amikacin Review and Amikacin Label ), CASPOFUNGIN (View Caspofungin Review and Caspofungin Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), CEFEPIME (View Cefepime Review and Cefepime Label ).

6960166-6 | Liver Function Test Abnormal
on Aug 23, 2010 Male patient from UNITED KINGDOM , 55 years of age, was diagnosed with brain abscess and was treated with Meropenem (View Usage). After Meropenem was administered, patient had the following side effects: liver function test abnormal. Meropenem dosage: . During the same period patient was treated with OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), CEFTRIAXONE (View Ceftriaxone Review and Ceftriaxone Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ).

6938516-6 | Cardiopulmonary Failure, Vital Functions Abnormal
Patient was taking Meropenem (View Usage). Patient experienced the following unwanted or unexpected effects: cardiopulmonary failure, vital functions abnormal on Aug 20, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 38 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?) and. Meropenem dosage: .

6894602-0 | Depressed Level Of Consciousness, Gastrointestinal Haemorrhage, Pseudomembranous Colitis
Adverse event was reported on Jul 22, 2010 by a Male patient taking Meropenem (View Usage) (Dosage: ) was diagnosed with pneumonia aspiration, immunisation, cardiac failure and. Location: SWEDEN , 78 years of age, Patient had the following side effects: depressed level of consciousness, gastrointestinal haemorrhage, pseudomembranous colitis. During the same period patient was treated with PANDEMRIX (View Pandemrix Review and Pandemrix Label ), TROMBYL (View Trombyl Review and Trombyl Label ), HEMINEVRIN (View Heminevrin Review and Heminevrin Label ), ATACAND (View Atacand Review and Atacand Label ), RISPERDAL (View Risperdal Review and Risperdal Label ), PEVARYL (View Pevaryl Review and Pevaryl Label ), AMARYL (View Amaryl Review and Amaryl Label ), NULYTELY (View Nulytely Review and Nulytely Label ). Patient was hospitalized.

6894520-8 | Eosinophilia, Toxic Skin Eruption
on Jul 22, 2010 Female patient from FRANCE , 72 years of age, was diagnosed with meningism and was treated with Meropenem (View Usage). After Meropenem was administered, patient had the following side effects: eosinophilia, toxic skin eruption. Meropenem dosage: . During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ). Patient was hospitalized.

6816899-5 | Chills, Excoriation, Exfoliative Rash, Eyelid Margin Crusting, Pyrexia, Staphylococcal Skin Infection, Toxic Skin Eruption
on Jun 28, 2010 Female patient from UNITED KINGDOM , 72 years of age, was diagnosed with neutropenic sepsis, hairy cell leukaemia and was treated with Meropenem (View Usage). Patient experienced the following unwanted or unexpected effects: chills, excoriation, exfoliative rash, eyelid margin crusting, pyrexia, staphylococcal skin infection, toxic skin eruption. Meropenem dosage: . During the same period patient was treated with DAPSONE (View Dapsone Review and Dapsone Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CALCICHEW D3 (View Calcichew D3 Review and Calcichew D3 Label ), CHONDROITIN (View Chondroitin Review and Chondroitin Label ), GLUCOSAMINE HYDROCHLORIDE (View Glucosamine Hydrochloride Review and Glucosamine Hydrochloride Label ), ISPAGHULA HUSK (View Ispaghula Husk Review and Ispaghula Husk Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ). Patient was hospitalized.

6768264-7 | Blood Pressure Decreased, Hypersensitivity, Skin Exfoliation, Skin Necrosis
Patient was taking Meropenem (View Usage). Patient had the following side effects: blood pressure decreased, hypersensitivity, skin exfoliation, skin necrosis on Jun 10, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 60 years of age, weighting 132.3 lb, was diagnosed with arthritis (What is arthritis?), cellulitis (What is cellulitis?) and. Meropenem dosage: . During the same period patient was treated with CEFTRIAXONE (View Ceftriaxone Review and Ceftriaxone Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), BUMETANIDE (View Bumetanide Review and Bumetanide Label ), HEPARIN (View Heparin Review and Heparin Label ), METOLAZONE (View Metolazone Review and Metolazone Label ). Patient was hospitalized.

6765872-4 | Stevens-johnson Syndrome
Adverse event was reported on Jun 09, 2010 by a Male patient taking Meropenem (View Usage) (Dosage: ) was diagnosed with osteomyelitis, prophylaxis and. Location: UNITED KINGDOM , 48 years of age, After Meropenem was administered, patient had the following side effects: stevens-johnson syndrome. During the same period patient was treated with CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), AMPICILLIN SODIUM/SULBACTAM SODIUM (View Ampicillin Sodium/sulbactam Sodium Review and Ampicillin Sodium/sulbactam Sodium Label ), ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), EZETIMIBE (View Ezetimibe Review and Ezetimibe Label ), FEXOFENADINE (View Fexofenadine Review and Fexofenadine Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ), HYPURIN BOVINE ISOPHANE (View Hypurin Bovine Isophane Review and Hypurin Bovine Isophane Label ).

6765215-6 | Chills, Infusion Related Reaction, Respiratory Rate Increased, Tachycardia, Tremor
on Jun 10, 2010 Female patient from UNITED STATES , child 4 years of age, weighting 43.21 lb, was diagnosed with infection (What is infection?) and was treated with Meropenem (View Usage). Patient experienced the following unwanted or unexpected effects: chills, infusion related reaction, respiratory rate increased, tachycardia, tremor. Meropenem dosage: . During the same period patient was treated with CHLOROTHIAZIDE (View Chlorothiazide Review and Chlorothiazide Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), NEB BUDESONIDE (View Neb-budesonide Review and Neb-budesonide Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6751112-9 | Pulse Absent, Skin Discolouration
on May 26, 2010 Female patient from UNITED STATES , 27 years of age, was treated with Meropenem (View Usage). Patient had the following side effects: pulse absent, skin discolouration. Meropenem dosage: . During the same period patient was treated with SODIUM CHLORIDE (View Sodium Chloride Review and Sodium Chloride Label ), CIPROFLOXACIN IN DEXTROSE (View Ciprofloxacin In Dextrose Review and Ciprofloxacin In Dextrose Label ), FENTANYL CITRATE (By Pharmedium) (View Fentanyl Citrate Review and Fentanyl Citrate Label ).

6725156-7 | Hyphaema, Intraocular Pressure Increased
Patient was taking Meropenem (View Usage). After Meropenem was administered, patient had the following side effects: hyphaema, intraocular pressure increased on May 07, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 70 years of age, . Meropenem dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), TEICOPLANIN (View Teicoplanin Review and Teicoplanin Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ).

6699136-4 | Blood Pressure Decreased, Hypersensitivity, Skin Exfoliation, Skin Necrosis
Adverse event was reported on Apr 23, 2010 by a Female patient taking Meropenem (View Usage) (Dosage: ) was diagnosed with arthritis (What is arthritis?), cellulitis (What is cellulitis?) and. Location: UNITED KINGDOM , 60 years of age, Patient experienced the following unwanted or unexpected effects: blood pressure decreased, hypersensitivity, skin exfoliation, skin necrosis. During the same period patient was treated with CEFTRIAXONE (View Ceftriaxone Review and Ceftriaxone Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), BUMETANIDE (View Bumetanide Review and Bumetanide Label ), HEPARIN (View Heparin Review and Heparin Label ), METOLAZONE (View Metolazone Review and Metolazone Label ). Patient was hospitalized.

6688258-X | Dermatitis Exfoliative, Escherichia Urinary Tract Infection, Pruritus
on Apr 14, 2010 Female patient from UNITED KINGDOM , 75 years of age, was diagnosed with escherichia urinary tract infection, osteoporosis (What is osteoporosis?) and was treated with Meropenem (View Usage). Patient had the following side effects: dermatitis exfoliative, escherichia urinary tract infection, pruritus. Meropenem dosage: . During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), PROTELOS (View Protelos Review and Protelos Label ), CALCICHEW (View Calcichew Review and Calcichew Label ), CO AMILOFRUSE (View Co-amilofruse Review and Co-amilofruse Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ). Patient was hospitalized.

6678690-2 | Cardiopulmonary Failure, Vital Functions Abnormal
on Apr 12, 2010 Male patient from UNITED KINGDOM , 38 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?) and was treated with Meropenem (View Usage). After Meropenem was administered, patient had the following side effects: cardiopulmonary failure, vital functions abnormal. Meropenem dosage: .

6674369-1 | Mouth Ulceration
Patient was taking Meropenem (View Usage). Patient experienced the following unwanted or unexpected effects: mouth ulceration on Apr 06, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 44 years of age, weighting 224.9 lb, was diagnosed with infected skin ulcer and. Meropenem dosage: . During the same period patient was treated with ROSUVASTATIN (View Rosuvastatin Review and Rosuvastatin Label ), CYCLIZINE (View Cyclizine Review and Cyclizine Label ), DICLOFENAC SODIUM (View Diclofenac Sodium Review and Diclofenac Sodium Label ), DULOXETINE HYDROCHLORIDE (View Duloxetine Hydrochloride Review and Duloxetine Hydrochloride Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), INSULIN (View Insulin Review and Insulin Label ), LINEZOLID (View Linezolid Review and Linezolid Label ), NEFOPAM (View Nefopam Review and Nefopam Label ).

6672660-6 | Hypokalaemia, Ileus Paralytic, Metabolic Alkalosis, Muscular Weakness, Ventricular Extrasystoles, Weaning Failure
Adverse event was reported on Mar 31, 2010 by a Female patient taking Meropenem (View Usage) (Dosage: ) was diagnosed with resuscitation and. Location: INDIA , 45 years of age, Patient had the following side effects: hypokalaemia, ileus paralytic, metabolic alkalosis, muscular weakness, ventricular extrasystoles, weaning failure. During the same period patient was treated with CRYSTALLOIDS (View Crystalloids Review and Crystalloids Label ), CEFOPERAZONE SULBACTAM (View Cefoperazone Sulbactam Review and Cefoperazone Sulbactam Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), NEUROMUSCULAR BLOCKERS (View Neuromuscular Blockers Review and Neuromuscular Blockers Label ), CORTICOSTEROIDS (At A Low Dose) (View Corticosteroids Review and Corticosteroids Label ), INOTROPES (View Inotropes Review and Inotropes Label ). Patient was hospitalized.

6639807-9 | Interstitial Lung Disease
on Mar 08, 2010 Male patient from JAPAN , 82 years of age, was diagnosed with pneumonia (What is pneumonia?), peptic ulcer haemorrhage, gastrointestinal disorder, hypertension, insomnia, asthma (What is asthma?) and was treated with Meropenem (View Usage). After Meropenem was administered, patient had the following side effects: interstitial lung disease. Meropenem dosage: . During the same period patient was treated with OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), NU LOTAN (View Nu-lotan Review and Nu-lotan Label ), DEPAS (View Depas Review and Depas Label ), CLARITH (View Clarith Review and Clarith Label ), ONON (View Onon Review and Onon Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), ADOAIR (View Adoair Review and Adoair Label ). Patient was hospitalized.

6634277-9 | Erythropenia, Leukopenia, Thrombocytopenia
on Mar 05, 2010 Female patient from JAPAN , 82 years of age, was diagnosed with pneumonia (What is pneumonia?) and was treated with Meropenem (View Usage). Patient experienced the following unwanted or unexpected effects: erythropenia, leukopenia, thrombocytopenia. Meropenem dosage: . During the same period patient was treated with TARGOCID (View Targocid Review and Targocid Label ).

6608386-4 | Interstitial Lung Disease
Patient was taking Meropenem (View Usage). Patient had the following side effects: interstitial lung disease on Feb 18, 2010 from JAPAN Additional patient health information: Male patient , 82 years of age, was diagnosed with pneumonia (What is pneumonia?), peptic ulcer haemorrhage, gastrointestinal disorder, hypertension, insomnia, asthma (What is asthma?) and. Meropenem dosage: . During the same period patient was treated with OMEPRAL (View Omepral Review and Omepral Label ), TAKEPRON (View Takepron Review and Takepron Label ), NU LOTAN (View Nu-lotan Review and Nu-lotan Label ), DEPAS (View Depas Review and Depas Label ), CLARITH (View Clarith Review and Clarith Label ), ONON (View Onon Review and Onon Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), ADOAIR (View Adoair Review and Adoair Label ). Patient was hospitalized.

6606567-7 | Depressed Level Of Consciousness
Adverse event was reported on Feb 17, 2010 by a Female patient taking Meropenem (View Usage) (Dosage: ) was diagnosed with infection (What is infection?) and. Location: JAPAN , 70 years of age, After Meropenem was administered, patient had the following side effects: depressed level of consciousness.

6605126-X | Blood Chloride Increased, Blood Sodium Increased, Blood Urea Increased, Condition Aggravated, Hepatic Function Abnormal, Platelet Count Decreased, Pneumonia, Renal Impairment, Respiratory Failure
on Feb 18, 2010 Female patient from JAPAN , 80 years of age, was diagnosed with pneumonia (What is pneumonia?), sputum retention and was treated with Meropenem (View Usage). Patient experienced the following unwanted or unexpected effects: blood chloride increased, blood sodium increased, blood urea increased, condition aggravated, hepatic function abnormal, platelet count decreased, pneumonia (What is pneumonia?), renal impairment, respiratory failure. Meropenem dosage: . During the same period patient was treated with BISOLVON (View Bisolvon Review and Bisolvon Label ), PENTCILLIN (View Pentcillin Review and Pentcillin Label ).

6601880-1 | Hepatic Function Abnormal
on Feb 16, 2010 Male patient from JAPAN , 60 years of age, was diagnosed with pancreatitis acute and was treated with Meropenem (View Usage). Patient had the following side effects: hepatic function abnormal. Meropenem dosage: . During the same period patient was treated with TANNALBIN (View Tannalbin Review and Tannalbin Label ), COLIOPAN (View Coliopan Review and Coliopan Label ). Patient was hospitalized.

6588361-9 | Cardiac Failure, Interstitial Lung Disease
Patient was taking Meropenem (View Usage). After Meropenem was administered, patient had the following side effects: cardiac failure, interstitial lung disease on Feb 08, 2010 from JAPAN Additional patient health information: Male patient , 77 years of age, was diagnosed with meningitis (What is meningitis?), gastric ulcer, benign prostatic hyperplasia, gastritis, insomnia, hypertension, meningitis bacterial, cardiac failure and. Meropenem dosage: . During the same period patient was treated with OMEPRAL (View Omepral Review and Omepral Label ), URINORM (View Urinorm Review and Urinorm Label ), RADEN (View Raden Review and Raden Label ), SORENTMIN (View Sorentmin Review and Sorentmin Label ), NU LOTAN (View Nu-lotan Review and Nu-lotan Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), GLYMACKEN (View Glymacken Review and Glymacken Label ), LASIX (View Lasix Review and Lasix Label ). Patient was hospitalized.

6585007-0 | Blood Chloride Increased, Blood Sodium Increased, Blood Urea Increased, Hepatic Function Abnormal, Platelet Count Decreased, Renal Impairment
Adverse event was reported on Feb 12, 2010 by a Female patient taking Meropenem (View Usage) (Dosage: ) was diagnosed with pneumonia (What is pneumonia?) and. Location: JAPAN , 80 years of age, Patient experienced the following unwanted or unexpected effects: blood chloride increased, blood sodium increased, blood urea increased, hepatic function abnormal, platelet count decreased, renal impairment.

6581244-X | Depressed Level Of Consciousness
on Feb 04, 2010 Female patient from JAPAN , 70 years of age, was diagnosed with infection (What is infection?) and was treated with Meropenem (View Usage). Patient had the following side effects: depressed level of consciousness. Meropenem dosage: .

6580285-6 | Depressed Level Of Consciousness
on Feb 01, 2010 Male patient from JAPAN , 74 years of age, was diagnosed with pneumonia (What is pneumonia?), respiratory failure, insomnia, atrial fibrillation (What is atrial fibrillation?) and was treated with Meropenem (View Usage). After Meropenem was administered, patient had the following side effects: depressed level of consciousness. Meropenem dosage: . During the same period patient was treated with MINOPEN (View Minopen Review and Minopen Label ), DIFLUCAN (View Diflucan Review and Diflucan Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), VENOGLOBULIN (View Venoglobulin Review and Venoglobulin Label ), MYSLEE (View Myslee Review and Myslee Label ), RISPERDAL (View Risperdal Review and Risperdal Label ), DIGOSIN (View Digosin Review and Digosin Label ). Patient was hospitalized.

6580061-4 | Jaundice, Platelet Count Decreased
Patient was taking Meropenem (View Usage). Patient experienced the following unwanted or unexpected effects: jaundice (What is jaundice?), platelet count decreased on Feb 02, 2010 from JAPAN Additional patient health information: Male patient , 28 years of age, was diagnosed with disseminated intravascular coagulation, pyrexia and. Meropenem dosage: . During the same period patient was treated with PRODIF (View Prodif Review and Prodif Label ), CEFMETAZOLE (View Cefmetazole Review and Cefmetazole Label ), GASTER (View Gaster Review and Gaster Label ).

6490285-2 | Blood Bilirubin Increased, Clostridium Difficile Colitis, Neutropenic Sepsis, Platelet Count Decreased
Adverse event was reported on Nov 17, 2009 by a Female patient taking Meropenem (View Usage) (Dosage: ) was diagnosed with infection (What is infection?), neutropenic sepsis, antibiotic prophylaxis and. Location: UNITED KINGDOM , 40 years of age, Patient had the following side effects: blood bilirubin increased, clostridium difficile colitis, neutropenic sepsis, platelet count decreased. Patient was hospitalized.

6462095-3 | Blood Bilirubin Increased, Clostridium Difficile Colitis, Neutropenic Sepsis, Platelet Count Decreased
on Nov 17, 2009 Female patient from UNITED KINGDOM , 40 years of age, was diagnosed with infection (What is infection?), neutropenic sepsis, antibiotic prophylaxis and was treated with Meropenem (View Usage). After Meropenem was administered, patient had the following side effects: blood bilirubin increased, clostridium difficile colitis, neutropenic sepsis, platelet count decreased. Meropenem dosage: . Patient was hospitalized.

6421537-X | Agranulocytosis, Neutropenia, Pancytopenia
on Oct 27, 2009 Male patient from DENMARK , 72 years of age, was diagnosed with sepsis (What is sepsis?) and was treated with Meropenem (View Usage). Patient experienced the following unwanted or unexpected effects: agranulocytosis, neutropenia, pancytopenia. Meropenem dosage: 2g X 2.

6417799-5 | Neutropenia
Patient was taking Meropenem (View Usage). Patient had the following side effects: neutropenia on Oct 27, 2009 from UNITED STATES Additional patient health information: Male patient , 68 years of age, weighting 187.4 lb, was diagnosed with meningitis (What is meningitis?) and. Meropenem dosage: 2gm Iv Q 8. During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), DOCUSATE (View Docusate Review and Docusate Label ), FILGRASTIM (View Filgrastim Review and Filgrastim Label ), INSULIN HIGH SS (View Insulin High Ss Review and Insulin High Ss Label ), KEPPRA (View Keppra Review and Keppra Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), LANSOPROZOLE (View Lansoprozole Review and Lansoprozole Label ).

6417727-2 | Infection Susceptibility Increased, Serratia Infection, White Blood Cell Count Decreased
Adverse event was reported on Oct 27, 2009 by a Male patient taking Meropenem (View Usage) (Dosage: 2g Iv Q 8?) was diagnosed with meningitis (What is meningitis?) and. Location: UNITED STATES , weighting 187.4 lb, After Meropenem was administered, patient had the following side effects: infection susceptibility increased, serratia infection, white blood cell count decreased. During the same period patient was treated with INSULIN ASPART (View Insulin Aspart Review and Insulin Aspart Label ), BISACODYL (View Bisacodyl Review and Bisacodyl Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), SENNA (View Senna Review and Senna Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), LEVETIRACETAM (View Levetiracetam Review and Levetiracetam Label ), HEPARIN (View Heparin Review and Heparin Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ). Patient was hospitalized.

6408939-2 | Diarrhoea
on Mar 18, 2009 Male patient from UNITED STATES , 63 years of age, was treated with Meropenem (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea. Meropenem dosage: . During the same period patient was treated with CEFTRIAXONE (View Ceftriaxone Review and Ceftriaxone Label ), DOXYCYCLINE (View Doxycycline Review and Doxycycline Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ). Patient was hospitalized.

6408937-9 | Leukopenia
on May 05, 2009 Male patient from UNITED STATES , 14 years of age, was diagnosed with meningitis streptococcal and was treated with Meropenem (View Usage). Patient had the following side effects: leukopenia. Meropenem dosage: . During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ).

6408053-6 | Cholangitis Acute, Granulomatous Liver Disease, Renal Impairment, Systemic Inflammatory Response Syndrome
Patient was taking Meropenem (View Usage). After Meropenem was administered, patient had the following side effects: cholangitis acute, granulomatous liver disease, renal impairment, systemic inflammatory response syndrome on Oct 19, 2009 from AUSTRALIA Additional patient health information: Male patient , 66 years of age, was diagnosed with percutaneous coronary intervention, stent placement and. Meropenem dosage: Unk. During the same period patient was treated with TICARCILLIN CLAVULANATE (Unk) (View Ticarcillin-clavulanate Review and Ticarcillin-clavulanate Label ), OMEPRAZOLE (Unk) (View Omeprazole Review and Omeprazole Label ), SIMVASTATIN (Unk) (View Simvastatin Review and Simvastatin Label ), IRBESARTAN HYDROCHLOROTHIAZIDE (Unk) (View Irbesartan - Hydrochlorothiazide Review and Irbesartan - Hydrochlorothiazide Label ), ASPIRIN (Unk) (View Aspirin Review and Aspirin Label ), PLAVIX (View Plavix Review and Plavix Label ). Patient was hospitalized.

6401802-2 | Influenza
Adverse event was reported on Oct 06, 2009 by a Female patient taking Meropenem (View Usage) (Dosage: ) was diagnosed with infection (What is infection?), influenza and. Location: UNITED KINGDOM , 22 years of age, Patient experienced the following unwanted or unexpected effects: influenza. During the same period patient was treated with CASPOFUNGIN ACETATE (View Caspofungin Acetate Review and Caspofungin Acetate Label ), OSELTAMIVIR (View Oseltamivir Review and Oseltamivir Label ), TEICOPLANIN (View Teicoplanin Review and Teicoplanin Label ). Patient was hospitalized.

6377102-6 | Pruritus, Skin Exfoliation, Wheezing
on Sep 21, 2009 Female patient from UNITED STATES , 52 years of age, weighting 121.9 lb, was diagnosed with osteomyelitis and was treated with Meropenem (View Usage). Patient had the following side effects: pruritus, skin exfoliation, wheezing. Meropenem dosage: . During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ). Patient was hospitalized.

6366577-4 | Delayed Engraftment, Hepatic Function Abnormal, Multi-organ Failure, Renal Impairment
on Aug 25, 2009 Male patient from JAPAN , 61 years of age, weighting 130.1 lb, was diagnosed with sepsis (What is sepsis?), systemic mycosis, immunodeficiency common variable and was treated with Meropenem (View Usage). After Meropenem was administered, patient had the following side effects: delayed engraftment, hepatic function abnormal, multi-organ failure, renal impairment. Meropenem dosage: . During the same period patient was treated with AMBISOME (3 Vials/day (2.5mg/kg) 150mg) (View Ambisome Review and Ambisome Label ), ITRIZOLE (View Itrizole Review and Itrizole Label ), MODACIN (View Modacin Review and Modacin Label ), OMEPRAL (View Omepral Review and Omepral Label ), GAMIMUNE N 5% (View Gamimune N 5% Review and Gamimune N 5% Label ).

6345380-5 | Hepatic Function Abnormal, Renal Impairment
Patient was taking Meropenem (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic function abnormal, renal impairment on Aug 25, 2009 from JAPAN Additional patient health information: Male patient , 61 years of age, weighting 130.1 lb, was diagnosed with sepsis (What is sepsis?), systemic mycosis, immunodeficiency common variable and. Meropenem dosage: . During the same period patient was treated with AMBISOME (3 Vials/day (2.5mg/kg) 150mg) (View Ambisome Review and Ambisome Label ), ITRIZOLE (View Itrizole Review and Itrizole Label ), MODACIN (View Modacin Review and Modacin Label ), OMEPRAL (View Omepral Review and Omepral Label ), GAMIMUNE N 5% (View Gamimune N 5% Review and Gamimune N 5% Label ).

6344288-9 | Colitis, Septic Shock
Adverse event was reported on Sep 04, 2009 by a Female patient taking Meropenem (View Usage) (Dosage: ) was diagnosed with pyrexia, diarrhoea and. Location: JAPAN , 81 years of age, Patient had the following side effects: colitis, septic shock. During the same period patient was treated with AMPICILLIN SODIUM (View Ampicillin Sodium Review and Ampicillin Sodium Label ), CEFAZOLIN (View Cefazolin Review and Cefazolin Label ), CEFACAPENE PIVOXIL HYDROCHLORIDE (View Cefacapene Pivoxil Hydrochloride Review and Cefacapene Pivoxil Hydrochloride Label ).

6316192-3 | Colitis, Septic Shock
on Aug 18, 2009 Female patient from JAPAN , 81 years of age, was diagnosed with pyrexia, diarrhoea and was treated with Meropenem (View Usage). After Meropenem was administered, patient had the following side effects: colitis, septic shock. Meropenem dosage: . During the same period patient was treated with AMPICILLIN SODIUM (View Ampicillin Sodium Review and Ampicillin Sodium Label ), CEFAZOLIN (View Cefazolin Review and Cefazolin Label ), CEFACAPENE PIVOXIL HYDROCHLORIDE (View Cefacapene Pivoxil Hydrochloride Review and Cefacapene Pivoxil Hydrochloride Label ).

6294641-7 | Leukoencephalopathy
on Jul 30, 2009 Female patient from GERMANY , weighting 143.3 lb, was diagnosed with febrile neutropenia and was treated with Meropenem (View Usage). Patient experienced the following unwanted or unexpected effects: leukoencephalopathy. Meropenem dosage: .

6237985-7 | Pancytopenia
Patient was taking Meropenem (View Usage). Patient had the following side effects: pancytopenia on Jun 18, 2009 from UNITED KINGDOM Additional patient health information: Female patient , weighting 88.18 lb, was diagnosed with enterobacter infection, enterococcal infection, thrombosis prophylaxis, pain (What is pain?), anaemia prophylaxis, mineral supplementation and. Meropenem dosage: . During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), SANDOCAL 1000 (View Sandocal 1000 Review and Sandocal 1000 Label ).